Brief: Hamlet Pharma: Successful Outcome In Alpha1H Clinical Trial

HAMLET Pharma AB

18/07/2019 09:46

July 18 (Reuters) - Hamlet Pharma AB  HAMLET.TE :
    * HAMLET PHARMA ANNOUNCES RESULTS OF FIRST MAJOR CLINICAL
TRIAL
FOR A NEW CANCER KILLING MOLECULE
    * FIRST DATA ANALYSIS HAS REVEALED HIGHLY SIGNIFICANT
DIFFERENCES
BETWEEN ALPHA1H TREATED PATIENTS AND PLACEBO GROUP, FOR SEVERAL
CRUCIAL EFFICACY VARIABLES
    * TREATMENT WAS ALSO SHOWN TO BE SAFE, AS NO DRUG-RELATED
SIDE
EFFECTS WERE OBSERVED
    * SUCCESSFUL CLINICAL TRIAL - ALPHA1H SHOWS HIGH EFFICACY
WITHOUT
TOXICITY

Source text for Eikon:  ID:nWkr3D2dKv 
Further company coverage:  HAMLET.TE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))